Acceleron Pharma, a Cambridge, MA-based developer of biotech drugs designed to effect the growth of cells and tissues to treat diseases, plans to expand its workforce from 114 people now employed at the company to 160 or more workers by the end of 2009, company spokesman Steven Ertel says. The venture-backed biotech firm held an event today to celebrate the opening of its second Cambridge facility, where it keeps its corporate headquarters and one of its two protein manufacturing operations, according to a press release. The firm is also leasing 19,700 square feet of lab and office space in a third facility in Cambridge, bringing its total footprint in the city to 95,000 square feet, Ertel says.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
